ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 59 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $690 | -24.1% | 300 | 0.0% | 0.00% | – |
| Q1 2023 | $909 | +58.6% | 300 | 0.0% | 0.00% | – |
| Q4 2022 | $573 | -42.7% | 300 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | – | 300 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 300 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 300 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 300 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,651,825 | $19,358,000 | 6.60% |
| RTW INVESTMENTS, LP | 5,165,499 | $37,708,000 | 2.72% |
| Eversept Partners, LP | 97,495 | $711,714 | 0.33% |
| Seelaus Asset Management LLC | 14,300 | $104,000 | 0.09% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 1,765,315 | $8,827,000 | 0.08% |
| ALGERT GLOBAL LLC | 34,816 | $254,000 | 0.05% |
| BOOTHBAY FUND MANAGEMENT, LLC | 48,000 | $350,000 | 0.03% |
| OXFORD ASSET MANAGEMENT LLP | 211,115 | $1,540,000 | 0.03% |
| PRIMECAP MANAGEMENT CO/CA/ | 4,000,400 | $29,203,000 | 0.02% |
| PDT Partners, LLC | 66,965 | $489,000 | 0.02% |